80 related articles for article (PubMed ID: 16765027)
21. Expression of dominant-negative src-homology domain 2-containing protein tyrosine phosphatase-1 results in increased Syk tyrosine kinase activity and B cell activation.
Dustin LB; Plas DR; Wong J; Hu YT; Soto C; Chan AC; Thomas ML
J Immunol; 1999 Mar; 162(5):2717-24. PubMed ID: 10072516
[TBL] [Abstract][Full Text] [Related]
22. Role of the protein tyrosine phosphatase SHP-1 (Src homology phosphatase-1) in the regulation of interleukin-3-induced survival, proliferation and signalling.
Paling NR; Welham MJ
Biochem J; 2002 Dec; 368(Pt 3):885-94. PubMed ID: 12220225
[TBL] [Abstract][Full Text] [Related]
23. [Sphingosine kinase regulates hepatocyte growth factor-induced migration of endothelial cells].
Yi J; Lu ZZ; Duan HF; Gai LY; Wang LS
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2006 May; 22(2):230-4. PubMed ID: 21162249
[TBL] [Abstract][Full Text] [Related]
24. Abnormal mesoderm patterning in mouse embryos mutant for the SH2 tyrosine phosphatase Shp-2.
Saxton TM; Henkemeyer M; Gasca S; Shen R; Rossi DJ; Shalaby F; Feng GS; Pawson T
EMBO J; 1997 May; 16(9):2352-64. PubMed ID: 9171349
[TBL] [Abstract][Full Text] [Related]
25. EDG-1 links the PDGF receptor to Src and focal adhesion kinase activation leading to lamellipodia formation and cell migration.
Rosenfeldt HM; Hobson JP; Maceyka M; Olivera A; Nava VE; Milstien S; Spiegel S
FASEB J; 2001 Dec; 15(14):2649-59. PubMed ID: 11726541
[TBL] [Abstract][Full Text] [Related]
26. Negative regulation of myeloid cell proliferation and function by the SH2 domain-containing tyrosine phosphatase-1.
Dong Q; Siminovitch KA; Fialkow L; Fukushima T; Downey GP
J Immunol; 1999 Mar; 162(6):3220-30. PubMed ID: 10092773
[TBL] [Abstract][Full Text] [Related]
27. Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 (janus kinase 2) and induction of Stat5 (signal transducer and activator of transcription 5)-dependent transcription.
Berchtold S; Volarevic S; Moriggl R; Mercep M; Groner B
Mol Endocrinol; 1998 Apr; 12(4):556-67. PubMed ID: 9544991
[TBL] [Abstract][Full Text] [Related]
28. A discoidin domain receptor 1/SHP-2 signaling complex inhibits alpha2beta1-integrin-mediated signal transducers and activators of transcription 1/3 activation and cell migration.
Wang CZ; Su HW; Hsu YC; Shen MR; Tang MJ
Mol Biol Cell; 2006 Jun; 17(6):2839-52. PubMed ID: 16611743
[TBL] [Abstract][Full Text] [Related]
29. The N-terminal SH2 domain of the tyrosine phosphatase, SHP-2, is essential for Jak2-dependent signaling via the angiotensin II type AT1 receptor.
Godeny MD; Sayyah J; VonDerLinden D; Johns M; Ostrov DA; Caldwell-Busby J; Sayeski PP
Cell Signal; 2007 Mar; 19(3):600-9. PubMed ID: 17027227
[TBL] [Abstract][Full Text] [Related]
30. Murine embryonic fibroblasts lacking TC-PTP display delayed G1 phase through defective NF-kappaB activation.
Ibarra-Sánchez MJ; Wagner J; Ong MT; Lampron C; Tremblay ML
Oncogene; 2001 Aug; 20(34):4728-39. PubMed ID: 11498795
[TBL] [Abstract][Full Text] [Related]
31. The tyrosine phosphatase SHP-2 regulates differentiation and apoptosis of individual primary T lymphocytes.
Hoff H; Brunner-Weinzierl MC
Eur J Immunol; 2007 Apr; 37(4):1072-86. PubMed ID: 17330819
[TBL] [Abstract][Full Text] [Related]
32. Peroxisome proliferator-activated receptor gamma ligands inhibit Rho/Rho kinase pathway by inducing protein tyrosine phosphatase SHP-2.
Wakino S; Hayashi K; Kanda T; Tatematsu S; Homma K; Yoshioka K; Takamatsu I; Saruta T
Circ Res; 2004 Sep; 95(5):e45-55. PubMed ID: 15308580
[TBL] [Abstract][Full Text] [Related]
33. Ligand stimulation of CD155alpha inhibits cell adhesion and enhances cell migration in fibroblasts.
Oda T; Ohka S; Nomoto A
Biochem Biophys Res Commun; 2004 Jul; 319(4):1253-64. PubMed ID: 15194502
[TBL] [Abstract][Full Text] [Related]
34. SHP-2-Erk signaling regulates concanavalin A-dependent production of TIMP-2.
Biswas MH; Hasegawa HH; Rahman MA; Huang P; Mon NN; Ruhul Amin AR; Senga T; Kannagi R; Hamaguchi M
Biochem Biophys Res Commun; 2006 Sep; 348(3):1145-9. PubMed ID: 16904070
[TBL] [Abstract][Full Text] [Related]
35. Antagonism or synergism. Role of tyrosine phosphatases SHP-1 and SHP-2 in growth factor signaling.
Wang N; Li Z; Ding R; Frank GD; Senbonmatsu T; Landon EJ; Inagami T; Zhao ZJ
J Biol Chem; 2006 Aug; 281(31):21878-21883. PubMed ID: 16762922
[TBL] [Abstract][Full Text] [Related]
36. A role for the SHP-2 tyrosine phosphatase in nerve growth-induced PC12 cell differentiation.
Wright JH; Drueckes P; Bartoe J; Zhao Z; Shen SH; Krebs EG
Mol Biol Cell; 1997 Aug; 8(8):1575-85. PubMed ID: 9285826
[TBL] [Abstract][Full Text] [Related]
37. SHP-2 regulates cell growth by controlling the mTOR/S6 kinase 1 pathway.
Zito CI; Qin H; Blenis J; Bennett AM
J Biol Chem; 2007 Mar; 282(10):6946-53. PubMed ID: 17229738
[TBL] [Abstract][Full Text] [Related]
38. [SHP tyrosine phosphatases and a novel cell-cell signaling system].
Matozaki T; Ohnishi H
Seikagaku; 2005 Oct; 77(10):1299-307. PubMed ID: 16296322
[No Abstract] [Full Text] [Related]
39. Biased suppression of hematopoiesis and multiple developmental defects in chimeric mice containing Shp-2 mutant cells.
Qu CK; Yu WM; Azzarelli B; Cooper S; Broxmeyer HE; Feng GS
Mol Cell Biol; 1998 Oct; 18(10):6075-82. PubMed ID: 9742124
[TBL] [Abstract][Full Text] [Related]
40. SHP-2 and myeloid malignancies.
Tartaglia M; Niemeyer CM; Shannon KM; Loh ML
Curr Opin Hematol; 2004 Jan; 11(1):44-50. PubMed ID: 14676626
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
